Compared to controls, patients reported higher baseline levels for WBC, neutrophils and lymphocyte subsets CD4.
Compared to controls, patients showed GM volume reductions in bilateral temporal lobes (p < 0.05; FDR-corrected).
Table 1 reports the demographics and clinical characteristics of the case and controls patients.
Compared to healthy controls, patients with ETTH in the out of pain phase exhibited similar GMD changes.
Compared to controls, patients more often had a high intensity score (p < 0.0001), but interobserver analyses revealed only moderate agreement.
As controls, patients who received heparin were matched for age, sex, body mass index and severity of illness scores.
Compared with controls, patients exhibited significant disinhibition (decreased positivity) of right frontal areas and greater activation of left temporal sites.
Compared with their matched controls, patients with SSSI had significantly longer LOS, higher mortality, and higher hospital charges.
Compared to controls, patients presented with a strictly ipsilateral distribution of qT1 increases in temporopolar, parahippocampal and orbitofrontal cortices.
However, compared with the controls, patients with FM reported more tender points and had higher TTS and HADS scores (all p < 0.001).
There was no difference between cases and controls patients considering gender, age, type of admission, and SAPS III and SOFA scores on ICU admission.
